Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Adm Policy Ment Health ; 30(2): 121-39, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12680617

ABSTRACT

The authors examined how differences in SSRI utilization affect the risk of hospitalization among persons with depression. In particular, they decompose how different types of drug therapy affect hospitalization and how that effect varies with the usage pattern of the drug. Using retrospective medical and pharmacy claims from a Midwestern health maintenance organization, they employed multiple logistic regression analyses of patients newly treated for depression. Their findings were that (a) paroxetine may be a significant risk factor for early discontinuation compared with fluoxetine; and (b) sertraline initiation among stable-use patients may lower the risk of hospitalization. However, initiation on paroxetine or sertraline rather than fluoxetine may increase the risk of hospitalization among patients not exhibiting a stable usage pattern.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Depressive Disorder/drug therapy , Drug Utilization Review , Hospitalization , Selective Serotonin Reuptake Inhibitors/therapeutic use , Antidepressive Agents, Second-Generation/adverse effects , Antidepressive Agents, Second-Generation/classification , Fluoxetine/adverse effects , Fluoxetine/therapeutic use , Health Maintenance Organizations , Humans , Medical Audit , Midwestern United States , Paroxetine/adverse effects , Paroxetine/therapeutic use , Retrospective Studies , Risk Factors , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/classification , Sertraline/adverse effects , Sertraline/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...